Archives of Gynecology and Obstetrics

, Volume 291, Issue 1, pp 185–191 | Cite as

The risk of ectopic pregnancy following GnRH agonist triggering compared with hCG triggering in GnRH antagonist ivf cycles

  • Sadik SahinEmail author
  • Alev Ozay
  • Elif Ergin
  • Lale Turkgeldi
  • Esra Kürüm
  • Hakan Ozornek
Gynecologic Endocrinology and Reproductive Medicine



The aim of this study was to compare the incidence of ectopic pregnancy in GnRH agonist triggered IVF cycles with intensive luteal support versus hCG triggered IVF cycles.


This study was conducted as a retrospective cohort analysis of women who underwent IVF treatment employing GnRH agonist or recombinant hCG (rhCG) triggers during 2-year period. The medical charts of women who achieved pregnancies were reviewed and their demographic characteristics, infertility reasons and IVF data were recorded. A multiple logistic regression analysis was performed to estimate the association between the triggering medication used to stimulate final oocyte maturation (GnRHa or rhCG) and EP, with adjustment for important confounders: the day of embryo transfer (ETD), the etiology of infertility and estrogen level at the time of triggering.


The number of metaphase II oocytes, fertilized oocytes and good quality embryos were significantly higher in the GnRH agonist triggered group compared with the hCG triggered group (p < 0.001 for all). The clinical pregnancy and implantation rates in the hCG triggered cycles were 38.6 and 31.1 %, respectively and 24.7 and 22 %, respectively in the triptorelin triggered cycles. The ectopic pregnancy rates were 5.3 % in the triptorelin triggered group and 1.4 % in the hCG triggered group. The trigger medication and the day of embryo transfer were found to have a significant effect on the probability of developing ectopic pregnancy (p = 0.028, p = 0.046 respectively). However, the estrogen level was not found to have a significant effect on the probability of developing ectopic pregnancy (p = 0.447).


The reasons for higher ectopic pregnancy rates in GnRH agonist triggered cycles relative to hCG triggered cycles may be the decreased receptivity of the endometrium due to insufficient luteal support and higher implantation potential of embryos in correlation with a higher number of good quality embryos obtained in these cycles.


GnRH agonist trigger Luteal support Ectopic pregnancy Clinical pregnancy hCG IVF 


Conflict of interest

All the authors state that there is no conflict of interest to disclose.


  1. 1.
    Clayton HB, Schieve LA, Peterson HB, Jamieson DJ, Reynolds MA, Wright VC (2006) Ectopic pregnancy risk with assisted reproductive technology procedures. Obstet Gynecol 107(3):595–604PubMedCrossRefGoogle Scholar
  2. 2.
    Chang HJ, Suh CS (2010) Ectopic pregnancy after assisted reproductive technology: what are the risk factors? Curr Opin Obstet Gynecol 22(3):202–207PubMedCrossRefGoogle Scholar
  3. 3.
    Itskovitz-Eldor J, Kol S, Mannaerts B (2000) Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication. Hum Reprod 15(9):1965–1968PubMedCrossRefGoogle Scholar
  4. 4.
    Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C (2008) The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril 89(1):84–91PubMedCrossRefGoogle Scholar
  5. 5.
    Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Grøndahl ML, Westergaard L, Andersen CY (2005) GnRH agonist (Buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomised study. Hum Reprod 20(5):1213–1220PubMedCrossRefGoogle Scholar
  6. 6.
    Kolibianakis EM, Schultze-Mosgau A, Schroer A, van Steirteghem A, Devroey P, Diedrich K, Griesinger G (2005) A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod 20(10):2887–2892PubMedCrossRefGoogle Scholar
  7. 7.
    Humaidan P, Papanikolaou EG, Tarlatzis BC (2009) GnRH agonist to triggered final oocyte maturation: a time to reconsider. Hum Reprod 24(10):2389–2394PubMedCrossRefGoogle Scholar
  8. 8.
    Cutting R, Morroll D, Roberts SA, Pickering S, Rutherford A (2008) Elective single embryo transfer: guidelines for practice British Fertility Society and Association of Clinical Embryologists. Hum Fertil (Camb) 11(3):131–146CrossRefGoogle Scholar
  9. 9.
    Imoedemhe DA, Sigue AB, Pacpaco EL, Olazo AB (1991) Stimulation of endogenous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation for in vitro fertilization. Fertil Steril 55(2):328–332PubMedGoogle Scholar
  10. 10.
    Oktay K, Türkçüoğlu I, Rodriguez-Wallberg Kenny A (2010) GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod BioMed Online 20(6):783–788PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Kol S, Humaidan P (2010) LH (as HCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango? Reprod Biomed Online 21(5):590–592PubMedCrossRefGoogle Scholar
  12. 12.
    Babayof R, Margalioth EJ, Huleihel M, Amash A, Zylber-Haran E, Gal M, Brooks B, Mimoni T, Eldar-Geva T (2006) Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Hum Reprod 21(5):1260–1265PubMedCrossRefGoogle Scholar
  13. 13.
    Orvieto R, Rabinson J, Meltzer S, Zohav E, Anteby E, Homburg R (2006) Substituting HCG with GnRH agonist to trigger final follicular maturation—a retrospective comparison of three different ovarian stimulation protocols. Reprod Biomed Online 13(2):198–201PubMedCrossRefGoogle Scholar
  14. 14.
    Orvieto R (2012) Intensive luteal-phase support with oestradiol and progesterone after GnRH-agonist triggering: does it help? Reprod Biomed Online 24(6):680–681PubMedCrossRefGoogle Scholar
  15. 15.
    Imbar T, Kol S, Lossos F, Bdolah Y, Hurwitz A, Haimov- Kochman R (2012) Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support. Hum Reprod 27(3):753–759PubMedCrossRefGoogle Scholar
  16. 16.
    Itskovitz J, Boldes R, Levron J, Erlik Y, Kahana L, Brandes JM (1991) Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril 56(2):213–220PubMedGoogle Scholar
  17. 17.
    Iliodromiti S, Blockeel C, Tremellen KP, Fleming R, Tournaye H, Humaidan P, Nelson SM (2013) Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study. Hum Reprod 28(9):2529–2536PubMedCrossRefGoogle Scholar
  18. 18.
    Iliodromiti S, Lan VT, Tuong HM, Tuan PH, Humaidan P, Nelson SM (2013) Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study. J Ovarian Res 26: 93.
  19. 19.
    Kummer N, Benadiva C, Feinn R, Mann J, Nulsen J, Engmann L (2011) Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist. Fertil Steril 96:63–68PubMedCrossRefGoogle Scholar
  20. 20.
    Humaidan P, Bredkjaer HE, Westergaard LG, Andersen CY (2010) 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertil Steril 93(3):847–854PubMedCrossRefGoogle Scholar
  21. 21.
    Bermejo A, Cerrillo M, Ruiz-Alonso M, Blesa D, Simón C, Pellicer A, Garcia-Velasco JA (2014) Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression. Fertil Steril 101(1):138–146.e3PubMedCrossRefGoogle Scholar
  22. 22.
    Humaidan P, Van Vaerenbergh I, Bourgain C, Alsbjerg B, Blockeel C, Schuit F (2012) Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist cotreated IVF cycles. Hum Reprod 27(11):3259–3272PubMedCrossRefGoogle Scholar
  23. 23.
    Fernandez H, Coste J, Job-Spira N (1991) Controlled ovarian hyperstimulation as a risk factor for ectopic pregnancy. Obstet Gynecol 78(4):656–659PubMedGoogle Scholar
  24. 24.
    Pyrgiotis E, Sultan KM, Neal GS, Liu HC, Grifo JA, Rosenwaks Z (1994) Ectopic pregnancies after in vitro fertilization and embryo transfer. J Assist Reprod Genet 11(2):79–84PubMedCrossRefGoogle Scholar
  25. 25.
    Marcus SF, Brinsden PR (1995) Analysis of the incidence and risk factors associated with ectopic pregnancy following in vitro fertilization and embryo transfer. Hum Reprod 10(1):199–203PubMedCrossRefGoogle Scholar
  26. 26.
    Wang J, Wei Y, Diao F, Cui Y, Mao Y, Wang W, Liu J (2013) The association between polycystic ovary syndrome and ectopic pregnancy after in vitro fertilization and embryo transfer. Am J Obstet Gynecol 209(2):139.e1–139.e9CrossRefGoogle Scholar
  27. 27.
    Wu Z, Li R, Ma Y, Deng B, Zhang X, Meng Y, Chen X, Liu P, Qiao J (2012) Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles. Reprod Biomed Online 24(5):511–520PubMedCrossRefGoogle Scholar
  28. 28.
    Zhu L, Li Y, Xu A (2012) Influence of controlled ovarian hyperstimulation on uterine peristalsis in infertile women. Hum Reprod 27(9):2684–2689PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Sadik Sahin
    • 1
    • 2
    Email author
  • Alev Ozay
    • 1
  • Elif Ergin
    • 1
  • Lale Turkgeldi
    • 2
  • Esra Kürüm
    • 3
  • Hakan Ozornek
    • 1
  1. 1.Eurofertil IVF CenterIstanbulTurkey
  2. 2.IVF Unit, Zeynep Kamil Maternity and Children’s HospitalIstanbulTurkey
  3. 3.Department of StatisticsIstanbul Medeniyet UniversityIstanbulTurkey

Personalised recommendations